Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

N-acetyltransferase 1 polymorphism increases cotinine levels in Caucasian children exposed to secondhand smoke: the CCAAPS birth cohort

Abstract

Cotinine is a proxy for secondhand smoke (SHS) exposure. Genetic variation along nicotine and cotinine metabolic pathways may alter the internal cotinine dose, leading to misinterpretations of exposure-health outcome associations. Caucasian children with available SHS exposure and hair cotinine data were genotyped for metabolism-related genes. SHS-exposed children had 2.4-fold higher hair cotinine (0.14±0.22 ng mg−1) than unexposed children (0.06±0.05 ng mg−1, P<0.001). SHS-exposed children carrying the NAT1 minor allele had twofold higher hair cotinine (0.18 ng mg−1 for heterozygotes and 0.17 ng mg−1 for homozygotes) compared with major allele homozygotes (0.09 ng mg−1, P=0.0009), even after adjustment for SHS dose. These findings support that NAT1 has a role in the metabolic pathway of nicotine/cotinine and/or their metabolites. The increased cotinine levels observed for those carrying the minor allele may lead to SHS exposure misclassification in studies utilizing cotinine as a biomarker. Additional studies are required to identify functional single-nucleotide polymorphism(s) (SNP(s)) in NAT1 and elucidate the biological consequences of the mutation(s).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. ACS. Secondhand Smoke and Children Fact Sheet. American Cancer Society: Atlanta, GA, 2006.

  2. California Environmental Protection Agency. Proposed Identification of Environmental Tobacco Smoke as a Toxic Air Contaminant. Air Resources Board and Office of Environmental Health Hazard Assessment. Sacramento, California, June 2005.

  3. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Department of Health and Human Services (ed). Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health: Atlanta, GA, 2006.

  4. Schuster MA, Franke T, Pham CB . Smoking patterns of household members and visitors in homes with children in the United States. Arch Pediatr Adolesc Med 2002; 156: 1094–1100.

    Article  Google Scholar 

  5. Benowitz N . Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996; 18: 188–204.

    Article  CAS  Google Scholar 

  6. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Department of Health and Human Services PHS, Office of the Surgeon General (ed): Rockville, MD, USA, p 17, 2010.

  7. Benowitz NL, Jacob P 3rd . Individual differences in nicotine kinetics and metabolism in humans. NIDA Res Monogr 1997; 173: 48–64.

    CAS  PubMed  Google Scholar 

  8. Benowitz NL, Jacob P 3rd . Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 1994; 56: 483–493.

    Article  CAS  Google Scholar 

  9. Perez-Stable EJ, Herrera B, Jacob P 3rd, Benowitz NL . Nicotine metabolism and intake in black and white smokers. JAMA 1998; 280: 152–156.

    Article  CAS  Google Scholar 

  10. Benowitz NL, Perez-Stable EJ, Herrera B, Jacob P 3rd . Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. J Natl Cancer Inst 2002; 94: 108–115.

    Article  Google Scholar 

  11. Benowitz NL, Hukkanen J, Jacob P 3rd . Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol 2009; 192: 29–60.

    Article  CAS  Google Scholar 

  12. Mwenifumbo JC, Tyndale RF . Molecular genetics of nicotine metabolism. Handb Exp Pharmacol 2009; 192: 235–259.

    Article  CAS  Google Scholar 

  13. Hukkanen J, Jacob P 3rd, Benowitz NL . Metabolism and disposition kinetics of nicotine. Pharmacol Rev 2005; 57: 79–115.

    Article  CAS  Google Scholar 

  14. Brandange S, Lindblom L . The enzyme "aldehyde oxidase" is an iminium oxidase. Reaction with nicotine delta 1'(5') iminium ion. Biochem Biophys Res Commun 1979; 91: 991–996.

    Article  CAS  Google Scholar 

  15. Brandange S, Lindblom L . Synthesis, structure and stability of nicotine delta1'(5') iminium ion, an intermediary metabolite of nicotine. Acta Chem Scand B 1979; 33: 187–191.

    Article  Google Scholar 

  16. Yamazaki H, Inoue K, Hashimoto M, Shimada T . Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes. Arch Toxicol 1999; 73: 65–70.

    Article  CAS  Google Scholar 

  17. Lang T, Klein K, Fischer J, Nussler AK, Neuhaus P, Hofmann U et al. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics 2001; 11: 399–415.

    Article  CAS  Google Scholar 

  18. Caporaso NE, Lerman C, Audrain J, Boyd NR, Main D, Issaq HJ et al. Nicotine metabolism and CYP2D6 phenotype in smokers. Cancer Epidemiol Biomarkers Prev 2001; 10: 261–263.

    CAS  PubMed  Google Scholar 

  19. van Vleet T, Bombick D, Coulombe RA Jr . Inhinition of human cytochrome p450 2E1 by nicotine, cotinine and aqueous cigarette tar extract in vivo. Toxicol Sci 2001; 64: 185–191.

    Article  CAS  Google Scholar 

  20. Messina ES, Tyndale RF, Sellers EM . A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 1997; 282: 1608–1614.

    CAS  PubMed  Google Scholar 

  21. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K et al. Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther 1996; 277: 1010–1015.

    CAS  PubMed  Google Scholar 

  22. Malaiyandi V, Goodz SD, Sellers EM, Tyndale RF . CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking. Cancer Epidemiol Biomarkers Prev 2006; 15: 1812–1819.

    Article  CAS  Google Scholar 

  23. Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R et al. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations. Clin Pharmacol Ther 2006; 80: 282–297.

    Article  CAS  Google Scholar 

  24. Yang M, Kunugita N, Kitagawa K, Kang SH, Coles B, Kadlubar FF et al. Individual differences in urinary cotinine levels in Japanese smokers: relation to genetic polymorphism of drug-metabolizing enzymes. Cancer Epidemiol Biomarkers Prev 2001; 10: 589–593.

    CAS  PubMed  Google Scholar 

  25. LeMasters GK, Wilson K, Levin L, Biagini J, Ryan P, Lockey JE et al. High prevalence of aeroallergen sensitization among infants of atopic parents. J Pediatr 2006; 149: 505–511.

    Article  Google Scholar 

  26. Biagini Myers JM, Khurana Hershey GK, Deka R, Burkle JW, Levin LS, Bernstein DI et al. Asking the right questions to ascertain early childhood secondhand smoke exposures. J Pediatr 2012; 160: 1050–1051.

    Article  Google Scholar 

  27. Eliopoulos C, Klein J, Phan MK, Knie B, Greenwald M, Chitayat D et al. Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA 1994; 271: 621–623.

    CAS  Google Scholar 

  28. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D . Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006; 38: 904–909.

    Article  CAS  Google Scholar 

  29. Narayanaswamy CR, Raghavarao D . Principal Component Analysis of Large Dispersion Matrices. Appl Stat J Roy St C 1991; 40: 309–316.

    Google Scholar 

  30. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575.

    Article  CAS  Google Scholar 

  31. Sim E, Walters K, Boukouvala S . Arylamine N-acetyltransferases: from structure to function. Drug Metab Rev 2008; 40: 479–510.

    Article  CAS  Google Scholar 

  32. McKennis H Jr, Turnbull LB, Bowman ER . N-Methylation of nicotine ad cotinine in vivo. J Biol Chem 1963; 238: 719–723.

    CAS  PubMed  Google Scholar 

  33. Neurath GB . Aspects of the oxidative metabolism of nicotine. Clin Invest 1994; 72: 190–195.

    Article  CAS  Google Scholar 

  34. Neurath GB, Pein FG . Gas chromatographic determination of trans-3'-hydroxycotinine, a major metabolite of nicotine in smokers. J Chromatogr 1987; 415: 400–406.

    Article  CAS  Google Scholar 

  35. Swan GE, Benowitz NL, Lessov CN, Jacob P 3rd, Tyndale RF, Wilhelmsen K . Nicotine metabolism: the impact of CYP2A6 on estimates of additive genetic influence. Pharmacogenet Genomics 2005; 15: 115–125.

    Article  CAS  Google Scholar 

  36. Keskitalo K, Broms U, Heliovaara M, Ripatti S, Surakka I, Perola M et al. Association of serum cotinine level with a cluster of three nicotinic acetylcholine receptor genes (CHRNA3/CHRNA5/CHRNB4) on chromosome 15. Hum Mol Genet 2009; 18: 4007–4012.

    Article  CAS  Google Scholar 

  37. Flegal KM, Brownie C, Haas JD . The effects of exposure misclassification on estimates of relative risk. Am J Epidemiol 1986; 123: 736–751.

    Article  CAS  Google Scholar 

  38. Schoedel KA, Hoffmann EB, Rao Y, Sellers EM, Tyndale RF . Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics 2004; 14: 615–626.

    Article  CAS  Google Scholar 

  39. Kubota T, Nakajima-Taniguchi C, Fukuda T, Funamoto M, Maeda M, Tange E et al. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation. Pharmacogenomics J 2006; 6: 115–119.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the clinic staff for their efforts in study coordination, recruitment, data management and data collection. We also thank all of the CCAAPS families for their time and commitment. This work was supported by the National Institute for Environmental Health Sciences grants R01-ES011170 and P30-ES006096.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J M Biagini Myers.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

LeMasters, G., Khurana Hershey, G., Sivaprasad, U. et al. N-acetyltransferase 1 polymorphism increases cotinine levels in Caucasian children exposed to secondhand smoke: the CCAAPS birth cohort. Pharmacogenomics J 15, 189–195 (2015). https://doi.org/10.1038/tpj.2014.44

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/tpj.2014.44

This article is cited by

Search

Quick links